{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T04:56:37Z","timestamp":1773464197747,"version":"3.50.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100005888","name":"Medical University of Lodz","doi-asserted-by":"crossref","award":["502-03\/5-108-03\/502-54-137"],"award-info":[{"award-number":["502-03\/5-108-03\/502-54-137"]}],"id":[{"id":"10.13039\/501100005888","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Reports"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.pharep.2018.05.005","type":"journal-article","created":{"date-parts":[[2018,8,22]],"date-time":"2018-08-22T23:40:32Z","timestamp":1534981232000},"page":"1032-1039","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Involvement of vascular endothelial growth factor (VEGF) and mitogen-activated protein kinases (MAPK) in the mechanism of neuroleptic drugs"],"prefix":"10.1007","volume":"70","author":[{"given":"Marta","family":"J\u00f3\u017awiak-B\u0119benista","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magdalena","family":"Jasi\u0144ska-Stroschein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward","family":"Kowalczyk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"10.1016\/j.pharep.2018.05.005_bib0005","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1038\/npp.2011.267","article-title":"Abnormal activity of the MAPK- and cAMP-associated signaling pathways in frontal cortical areas in postmortem brain in schizophrenia","volume":"37","author":"Funk","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharep.2018.05.005_bib0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2350-6-7","article-title":"Theories of schizophrenia: a genetic-inflammatory-vascular synthesis","volume":"6","author":"Hanson","year":"2005","journal-title":"BMC Med Genet"},{"key":"10.1016\/j.pharep.2018.05.005_bib0015","first-page":"240","article-title":"Coupling of brain activity and cerebral blood flow: basis of functional neuroimaging","volume":"7","author":"Villringer","year":"1995","journal-title":"Cerebrovasc Brain Metab Rev"},{"key":"10.1016\/j.pharep.2018.05.005_bib0020","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.schres.2009.06.005","article-title":"Decreased VEGF mRNA expression in the dorsolateral prefrontal cortex of schizophrenia subjects","volume":"115","author":"Fulzele","year":"2009","journal-title":"Schizophr Res"},{"key":"10.1016\/j.pharep.2018.05.005_bib0025","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1038\/nature04481","article-title":"From angiogenesis to neuropathology","volume":"438","author":"Greenberg","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.pharep.2018.05.005_bib0030","doi-asserted-by":"crossref","first-page":"e20198","DOI":"10.1371\/journal.pone.0020198","article-title":"Long-term continuous corticosterone treatment decreases VEGF receptor-2 expression in frontal cortex","volume":"6","author":"Howell","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.pharep.2018.05.005_bib0035","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.psychres.2015.04.020","article-title":"Alterations in plasma vascular endothelial growth factor levels in patients with schizophrenia before and after treatment","volume":"228","author":"Lee","year":"2015","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.pharep.2018.05.005_bib0040","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1007\/s40263-015-0278-3","article-title":"Update on the mechanism of action of aripiprazole: translational insights into antipsychotic strategies beyond dopamine receptor antagonism","volume":"9","author":"de Bartolomeis","year":"2015","journal-title":"CNS Drugs"},{"key":"10.1016\/j.pharep.2018.05.005_bib0045","first-page":"1","article-title":"Haloperidol versus first-generation antipsychotics for the treatment of schizophrenia and other psychotic disorders","volume":"1","author":"Dold","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.pharep.2018.05.005_bib0050","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/pcn.12242","article-title":"Psychopharmacology of atypical antipsychotic drugs: from the receptor binding profile to neuroprotection and neurogenesis","volume":"69","author":"Kusumi","year":"2015","journal-title":"Psychiatry Clin Neurosci"},{"key":"10.1016\/j.pharep.2018.05.005_bib0055","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1177\/070674370204700106","article-title":"Atypical antipsychotics: mechanism of action","volume":"47","author":"Seeman","year":"2002","journal-title":"Can J Psychiatry"},{"key":"10.1016\/j.pharep.2018.05.005_bib0060","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1007\/s11064-016-2127-2","article-title":"Neuroleptic drugs and PACAP differentially affect the mRNA expression of genes encoding PAC1\/VPAC type receptors","volume":"42","author":"J\u00f3\u017awiak-B\u0119benista","year":"2017","journal-title":"Neurochem Res"},{"key":"10.1016\/j.pharep.2018.05.005_bib0065","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.schres.2006.06.017","article-title":"Differential effects of haloperidol and olanzapine on levels of vascular endothelial growth factor and angiogenesis in rat hippocampus","volume":"87","author":"Pillai","year":"2006","journal-title":"Schizophr Res"},{"key":"10.1016\/j.pharep.2018.05.005_bib0070","article-title":"Vascular endothelial growth factor (VEGF) and its role in non-endothelial cells: autocrine signalling by VEGF madame curie bioscience database","author":"Duffy","year":"2011","journal-title":"Landes Bioscience"},{"issue":"144","key":"10.1016\/j.pharep.2018.05.005_bib0075","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.jsbmb.2014.07.009","article-title":"Tibolone protects T98G cells from glucose deprivation","volume":"214","author":"Avila Rodriguez","year":"2014","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.pharep.2018.05.005_bib0080","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/S0304-3940(00)01051-X","article-title":"Adenosine triphosphate affects interleukin-1beta release by T98G glioblastoma cells through a purinoceptorindependent mechanism","volume":"285","author":"de Joannon","year":"2000","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.pharep.2018.05.005_bib0085","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s12640-014-9509-5","article-title":"PDGF-BB protects mitochondria from rotenone in T98G cells","volume":"27","author":"Cabezas","year":"2015","journal-title":"Neurotox Res"},{"key":"10.1016\/j.pharep.2018.05.005_bib0090","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1097\/00001756-200104170-00011","article-title":"BDNF mediates the neuroprotective effect of PACAP-38 on rat cortical neurons","volume":"12","author":"Frechilla","year":"2001","journal-title":"Neuroreport"},{"key":"10.1016\/j.pharep.2018.05.005_bib0095","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.pharep.2014.10.001","article-title":"The cyclic AMP effects and neuroprotective activities of PACAP and VIP in cultured astrocytes and neurons exposed to oxygen-glucose deprivation","volume":"67","author":"J\u00f3\u017awiak-B\u0119benista","year":"2015","journal-title":"Pharmacol Rep"},{"key":"10.1016\/j.pharep.2018.05.005_bib0100","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/nprot.2008.73","article-title":"Analyzing real-time PCR data by the comparative C(T) method","volume":"3","author":"Schmittgen","year":"2008","journal-title":"Nat Protoc"},{"key":"10.1016\/j.pharep.2018.05.005_bib0105","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.biopha.2016.02.047","article-title":"Clozapine and olanzapine are better antioxidants than haloperidol, quetiapine, risperidone and ziprasidone in in vitro models","volume":"81","author":"Brinholi","year":"2016","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.pharep.2018.05.005_bib0110","doi-asserted-by":"crossref","first-page":"205","DOI":"10.21307\/ane-2017-054","article-title":"The differential effects of neuroleptic drugs and PACAP on the expression of BDNF mRNA and protein in a human glioblastoma cell line","volume":"77","author":"J\u00f3\u017awiak-B\u0119benista","year":"2017","journal-title":"Acta Neurobiol Exp (Wars)"},{"key":"10.1016\/j.pharep.2018.05.005_bib0115","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1385\/JMN:27:1:043","article-title":"Second-generation antipsychotic drugs, olanzapine, quetiapine, and clozapine enhance neurite outgrowth in PC12 cells via PI3K\/AKT, ERK, and pertussis toxin-sensitive pathways","volume":"27","author":"Lu","year":"2005","journal-title":"J Mol Neurosci"},{"key":"10.1016\/j.pharep.2018.05.005_bib0120","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.ejphar.2014.05.049","article-title":"Antipsychotics, chlorpromazine and haloperidol inhibit voltage-gated proton currents in BV2 microglial cells","volume":"738","author":"Shin","year":"2014","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharep.2018.05.005_bib0125","first-page":"32","article-title":"Antipsychotic drugs cause glial cell line-derived neurotrophic factor secretion from C6 glioma cells","volume":"31","author":"Shao","year":"2006","journal-title":"J Psychiatry Neurosci"},{"key":"10.1016\/j.pharep.2018.05.005_bib0130","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1002\/1097-4547(20000615)60:6<783::AID-JNR11>3.0.CO;2-M","article-title":"Brain-derived neurotrophic factor and tyrosine kinase receptor TrkB in rat brain are significantly altered after haloperidol and risperidone administration","volume":"60","author":"Angelucci","year":"2000","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.pharep.2018.05.005_bib0135","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1007\/s10571-015-0192-8","article-title":"Neurotrophic activity of cultured cell line U87 is up-regulated by proline-rich polypeptide complex and its constituent nonapeptide","volume":"35","author":"Zab\u0142ocka","year":"2015","journal-title":"Cell Mol Neurobiol"},{"key":"10.1016\/j.pharep.2018.05.005_bib0140","first-page":"720","article-title":"VEGF manipulation in glioblastoma","volume":"29","author":"Weathers","year":"2015","journal-title":"Oncology (Williston Park)"},{"key":"10.1016\/j.pharep.2018.05.005_bib0145","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s00406-009-0033-1","article-title":"Risperidone and haloperidol promote survival of stem cells in the rat hippocampus","volume":"260","author":"Keilhoff","year":"2010","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"10.1016\/j.pharep.2018.05.005_bib0150","doi-asserted-by":"crossref","first-page":"e0120526","DOI":"10.1371\/journal.pone.0120526","article-title":"PACAP enhances axon outgrowth in cultured hippocampal neurons to a comparable extent as BDNF","volume":"10","author":"Ogata","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.pharep.2018.05.005_bib0155","doi-asserted-by":"crossref","first-page":"L56","DOI":"10.1186\/2193-1801-4-S1-L56","article-title":"Neurochemical changes in different brain regions induced by PACAP \u2212 relations to neuroprotection","volume":"4","author":"Reglodi","year":"2015","journal-title":"Springerplus"},{"key":"10.1016\/j.pharep.2018.05.005_bib0160","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1002\/jcp.25616","article-title":"PACAP and VIP inhibit HIF-1\u03b1-mediated VEGF expression in a model of diabetic macular edema","volume":"232","author":"Maugeri","year":"2017","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.pharep.2018.05.005_bib0165","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.neulet.2012.06.044","article-title":"Effect of PACAP on MAP kinases, Akt and cytokine expressions in rat retinal hypoperfusion","volume":"523","author":"Szabo","year":"2012","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.pharep.2018.05.005_bib0170","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0006-8993(02)03215-8","article-title":"Differential regulation of hippocampal BDNF mRNA by typical and atypical antipsychotic administration","volume":"954","author":"Chlan-Fourney","year":"2002","journal-title":"Brain Res"},{"key":"10.1016\/j.pharep.2018.05.005_bib0175","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/00003246-200004001-00008","article-title":"MAP kinase pathways activated by stress: the p38 MAPK pathway","volume":"28","author":"Obata","year":"2000","journal-title":"Crit Care Med"},{"key":"10.1016\/j.pharep.2018.05.005_bib0180","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1046\/j.1471-4159.2000.0752327.x","article-title":"Haloperidol-induced neuronal apoptosis: role of p38 and c-Jun-NH(2)-terminal protein kinase","volume":"75","author":"Noh","year":"2000","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharep.2018.05.005_bib0185","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/S0006-2952(99)00156-2","article-title":"Effects of psychotropic drugs on cell proliferation and differentiation","volume":"58","author":"Nordenberg","year":"1999","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.pharep.2018.05.005_bib0190","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1080\/15622970410029909","article-title":"Inhibition of p38-mitogen-activated protein kinase may protect from clozapine-induced agranulocytosis","volume":"5","author":"Loeffler","year":"2004","journal-title":"World J Biol Psychiatry"},{"key":"10.1016\/j.pharep.2018.05.005_bib0195","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1002\/cncr.21574","article-title":"Reduced cancer incidence among patients with schizophrenia","volume":"104","author":"Barak","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.pharep.2018.05.005_bib0200","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/87895","article-title":"The neurotransmitter dopamine inhibits angiogenesis induced by vascular permeability factor\/vascular endothelial growth factor","volume":"7","author":"Basu","year":"2001","journal-title":"Nat Med"},{"key":"10.1016\/j.pharep.2018.05.005_bib0205","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/nrc1093","article-title":"Tumorigenesis and the angiogenic switch","volume":"3","author":"Bergers","year":"2003","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.pharep.2018.05.005_bib0210","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1002\/ijc.23562","article-title":"Reduced tumor growth in a mouse model of schizophrenia, lacking the dopamine transporter","volume":"123","author":"Asada","year":"2008","journal-title":"Int J Cancer"},{"key":"10.1016\/j.pharep.2018.05.005_bib0215","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s11102-012-0380-1","article-title":"Cabergoline reduces cell viability in non functioning pituitary adenomas by inhibiting vascular endothelial growth factor secretion","volume":"16","author":"Gagliano","year":"2013","journal-title":"Pituitary"},{"key":"10.1016\/j.pharep.2018.05.005_bib0220","first-page":"981","article-title":"Activation of p38 MAPK and\/or JNK contributes to increased levels of VEGF secretion in human malignant glioma cells","volume":"29","author":"Yoshino","year":"2006","journal-title":"Int J Oncol"},{"key":"10.1016\/j.pharep.2018.05.005_bib0225","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.mehy.2012.03.026","article-title":"Antipsychotic drugs: pro-cancer or anti-cancer? A systemic review","volume":"79","author":"Fond","year":"2012","journal-title":"Med Hypotheses"}],"container-title":["Pharmacological Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1734114017304905?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1734114017304905?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T20:37:40Z","timestamp":1752611860000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1016\/j.pharep.2018.05.005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":45,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["S1734114017304905"],"URL":"https:\/\/doi.org\/10.1016\/j.pharep.2018.05.005","relation":{},"ISSN":["1734-1140"],"issn-type":[{"value":"1734-1140","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Involvement of vascular endothelial growth factor (VEGF) and mitogen-activated protein kinases (MAPK) in the mechanism of neuroleptic drugs","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharep.2018.05.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Institute of Pharmacology, Polish Academy of Sciences. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}